Deals deals deals.
Biopharma M&A is having one of its best stretches in years, as big pharma buyers snap up smaller biotechs. We’ll be talking live about what’s going on and how this time seems different from prior signs of life in the merger market.
Tune in on YouTube Friday at 1:15 p.m. ET. I’ll be joined by our deals and financing expert Kyle LaHucik as we interview Emily Field, head of US biopharmaceuticals equity research at Barclays.
We’ll talk about why big companies are buying now, what type of assets they’re going after, what counts as a “big” deal these days and what all the cash coming back to investors means for the startup market.
At the rate things are going, we might have another merger announcement to talk about by the time the show comes around. In the meantime, you can set a calendar reminder for an alert when we go live.
See you then!
— Drew Armstrong, Executive Editor